Are Petropavlovsk plc, Schroders plc and Avocet Mining plc worth buying after today’s updates?

Do these 3 stocks offer appealing risk/reward ratios? Petropavlovsk plc (LON: POG), Schroders plc (LON: SDR) and Avocet Mining plc (LON: AVM)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Positioned well for future growth

Today’s interim management statement from asset manager Schroders (LSE: SDR) shows that the company is making encouraging progress in an uncertain market. It was able to increase assets under management from £313.5bn to £324.9bn, with that figure being boosted by net inflows of £2.7bn, as well as investment returns of £8.7bn during the period.

Although pre-tax profit fell from £142m in the first three months of last year to £138m in the first quarter of the current year, Schroders’ diversified business model positions the company well for future growth even in what is likely to be an uncertain period, with the EU referendum having the potential to cause high volatility in the short run.

With Schroders forecast to increase its bottom line by 7% next year and its shares having a price to earnings (P/E) ratio of just 14.8, it seems to offer good value for money given its excellent track record of growth. Therefore, while its short term performance has the potential to disappoint, Schroders remains a sound long term buy.

A wide margin of safety

Also reporting today was gold miner Petropavlovsk (LSE: POG), which confirmed production guidance for the full-year of 460,000–500,000 ounces of gold. This would be slightly down on 2015’s production of 504,100 ounces and reflects the company’s focus on cost reduction and operational efficiencies. Still, Petropavlovsk expects to deliver a 10-20% annual rise in production between 2017 and 2020 which, when combined with a fall in costs, could mean a sustained rise in profitability over the medium to long term.

As well as a production update, Petropavlovsk also announced the acquisition of Amur Zoloto, a Russian gold mining company, for $144m. It will be paid for out of the issuance of new shares and with Petropavlovsk also announcing a joint venture with LLC GMD Gold to finance the completion of the construction and commissioning of the company’s pressure oxidation hub project, it seems to be making strong progress.

With Petropavlovsk trading on a P/E ratio of just 4.8, it seems to offer a wide margin of safety — especially while the prospects for the gold price are so positive. Therefore, it seems to be a worthy purchase for less risk-averse investors.

Upbeat prospects

Meanwhile, shares in gold miner Avocet (LSE: AVM) have soared by over 40% today after it released a positive first quarter production update. Total gold production at Inata was 20,528 ounces at a cash cost of $925 per ounce. This is up from 17,379 ounces produced in the fourth quarter of last year, with costs falling from that quarter’s $1,094 per ounce. This rise in production and fall in costs is clearly positive news and has caused investor sentiment to rapidly rise.

Production in the first quarter benefitted from a period of treating cleaner ores, which enabled higher recoveries to be achieved. Throughput also improved, with 544k tonnes processed in the quarter versus 509k tonnes in the previous quarter. And with production from Inata in 2016 expected to be between 75,000 and 85,000 ounces, the company’s medium term prospects appear to be upbeat. Therefore, for investors with a higher tolerance of risk, Avocet could be worth a closer look.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »